New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. - Wikidata - wikimedia - TriplyDB

New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.

New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.

http://www.wikidata.org/entity/Q37201999

about

Ratio between negative and positive lymph nodes is suitable for evaluation the prognosis of gastric cancer patients with positive node metastasis.Negative node count improvement prognostic prediction of the seventh edition of the TNM classification for gastric cancer.Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer?Prognostic discrimination of subgrouping node-positive endometrioid uterine cancer: location vs nodal extent.Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer.Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer.Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer.The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy.Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes.Prognostic assessment of different metastatic lymph node staging methods for gastric cancer after D2 resection.Combined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancer Radical lymph node dissection and assessment: Impact on gallbladder cancer prognosis The Ratio-Based N Staging System Can More Accurately Reflect the Prognosis of T4 Gastric Cancer Patients with D2 Lymphadenectomy Compared with the 7th American Joint Committee on Cancer/Union for International Cancer Control Staging System.Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection.Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies.The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patients.Is lymphadenectomy a predictor or savior for patients with gastric cancer?Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience.The evaluation of metastatic lymph node ratio staging system in gastric cancer.Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy.Staging for Remnant Gastric Cancer: The Metastatic Lymph Node Ratio vs. the UICC 7th Edition System.A Nomogram for Predicting Overall Survival of Gastric Cancer Patients with Insufficient Lymph Nodes Examined.Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection--results of a single-institution study of 1343 Chinese patients.Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.

P2860

Q34405857-2F834EB1-5626-47D6-B465-0E3A3A63BEA3 Q35069303-68E8E602-C39C-4345-800E-B86E478B3E2F Q35424624-A77F0222-5884-4E91-BFAB-B6D0A2B73CE6 Q35527109-4F2AB30F-133E-4837-886C-DF9FC8CCFDEA Q35601941-12BF4265-1822-499B-91CC-CEDFAE9C6FF7 Q35606833-114236F7-A122-42BF-A3EE-03964BE4D79F Q36090138-4E92D203-0F3C-4B22-8354-A7B5E078660F Q36113713-8C273821-62F5-43E3-A38F-3308EA7605C5 Q36494006-3B19DFC9-E439-44EB-B1A4-9AF7A72477E5 Q36731208-D4703DDF-50B0-4614-A6FB-E530DADEC05F Q36952625-ACEB92DB-6FC4-441C-AE19-5DEED0458202 Q37102497-99CF9300-F41D-4AE2-AD9C-59F3EF175836 Q37549192-91ECF5F6-7DD4-4A99-BAA2-AAF7F1B114D1 Q37687566-EDC727F3-9FE6-48F2-A0DD-B7670BAAADBC Q38201682-61582F7B-2BC4-4B8F-AC27-5AA1BBCEA5A6 Q39793145-56BC547F-7985-4C39-B8E3-B60D82871D51 Q42834551-C211D0EE-44A2-4C6C-910A-A6FD0F503B2A Q44501869-F3AF969C-213A-41A6-B4C1-E16EFE26AA30 Q45110706-A17E012C-ACF7-4F36-9FA6-2008EE0EFD26 Q46019834-AA9E0A1A-6AC2-4D93-8F84-740BEA998CF0 Q48446915-A6EFD080-90AB-400A-B1D3-5553C0FEA3C0 Q52886143-D9E11208-E2F7-47AC-830C-523FD5050130 Q53159130-9FCF9FEC-24D0-4E2F-959F-FD3B2A6595C6 Q53517917-5B7D42B0-5AF9-413F-8FFC-74A8B74ED7CA

P2860

New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.

http://www.wikidata.org/entity/Q37201999

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 January 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New metastatic lymph node rati ...... my for gastric adenocarcinoma.

@en

New metastatic lymph node rati ...... my for gastric adenocarcinoma.

@nl

type

label

New metastatic lymph node rati ...... my for gastric adenocarcinoma.

@en

New metastatic lymph node rati ...... my for gastric adenocarcinoma.

@nl

prefLabel

New metastatic lymph node rati ...... my for gastric adenocarcinoma.

@en

New metastatic lymph node rati ...... my for gastric adenocarcinoma.

@nl

P1433

Q37201999-6C4E3587-6EF2-483D-B4AA-93EE97FF876E

P1476

Q37201999-EF3CC0C4-8FCF-4B5F-8171-E8CAC084EE92

P2093

Q37201999-7C84B09B-E626-43FF-BF9D-43E1CC9152D1

Q37201999-82CFD419-C0B5-4945-97E0-819E23F36E91

Q37201999-9D6D4D44-7FF2-4149-BC33-42D5EE661725

Q37201999-C5FBC7AA-143B-490A-83C1-F1B38826182C

Q37201999-D147A58F-9A9C-4A70-8B0E-93526E65CE96

Q37201999-E3AC1995-CC8A-448D-A563-B8F516243FC7

Q37201999-F87F7956-EAF3-4D96-8B11-A7C31813BE06

P2860

Q37201999-0F89E1C9-16C7-4E3D-8B89-524128B0B950

Q37201999-18CDE3D4-13E1-489C-9109-5EAF65B6C498

Q37201999-1D9EE45A-0C31-442E-9219-57878EEF88B6

Q37201999-3B7A076E-2C59-44E5-BC62-B169F7D58649

Q37201999-3C9484B5-1EF8-465E-B45B-B8B0CEA33E53

Q37201999-512FD521-FC3E-4E11-8F75-86A2F0C20399

Q37201999-51A14349-A186-48AE-85F2-4E2FC61E1C81

Q37201999-964498B6-9861-4F65-9A5B-C688B3C12213

Q37201999-99B51060-B22E-46E8-B7A6-01BEB1AAF1BE

Q37201999-AE73DFAA-4382-417B-9471-2DE33EF183F9

P2888

Q37201999-A7CFCD78-DFB4-48A6-BEB2-28975D610F90

P304

Q37201999-B80A4FFF-B475-4C30-A799-77722102CFCB

P31

Q37201999-7ECA780F-AFCF-4FBA-8DF5-D274BA867A1C

P356

Q37201999-7B22EC8B-A888-4311-83F4-7C64E866FCA2

P433

Q37201999-53C070C5-52F9-4D15-AA61-756CA5BF7F2D

P478

Q37201999-6BDF7501-EE9E-4FC7-A014-DFC6F2844C9B

P577

Q37201999-DC6878F9-E5CE-4FF2-AF60-EF58573D275F

P6179

Q37201999-DC028094-A7FD-4B13-9371-AF0496016826

P698

Q37201999-8EA5F31E-B194-4F94-ADFA-D2BE7291519C

P921

Q37201999-557A34A8-52F7-4CEE-81B9-6DF5B0DBD02E

Q37201999-A1DAD3F3-BA7F-4EE3-B828-CB3F07210FB7

Q37201999-B4922547-F145-4220-8288-F16F82602CAD

P932

Q37201999-0CD5705E-1F3A-44F2-8E3E-6B82D7BCE100

P356

S10434-010-0914-6

P1433

Annals of Surgical Oncology

P1476

New metastatic lymph node rati ...... my for gastric adenocarcinoma.

@en

P2093

Carlos Fernandez-Del-Castillo

http://www.w3.org/2001/XMLSchema#string

Charles M Ferguson

http://www.w3.org/2001/XMLSchema#string

David L Berger

http://www.w3.org/2001/XMLSchema#string

David W Rattner

http://www.w3.org/2001/XMLSchema#string

Gregory Y Lauwers

http://www.w3.org/2001/XMLSchema#string

Sam S Yoon

http://www.w3.org/2001/XMLSchema#string

Ugwuji N Maduekwe

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Cancer statistics, 2009

Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.

No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer.

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study.

Pathological staging and therapy of oesophageal and gastric cancer.

Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience.

Patterns of initial recurrence in completely resected gastric adenocarcinoma.

Metastatic lymph node ratio as a prognostic factor in gastric cancer.

P2888

s10434-010-0914-6

P304

1267-1277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-010-0914-6

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038707644

http://www.w3.org/2001/XMLSchema#string

P698

20099040

http://www.w3.org/2001/XMLSchema#string

P921

lymphadenectomy

P932

3785005

http://www.w3.org/2001/XMLSchema#string